NCT07779018 CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line Therapy Status RECRUITING Phase PHASE2
NCT07763054 Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients Status RECRUITING Phase N/A
NCT07739849 Flow on FNA/Core Project- Faster Diagnosis for Lymphoma: Utilising Flow Cytometry on FNA Samples of Lymph Nodes to Diagnose Lymphoma in Hours, Not Days. Status NOT_YET_RECRUITING Phase NA
NCT07714044 Rutgers University Study of the Genetics of Blood Cancers Status NOT_YET_RECRUITING Phase N/A
NCT07705178 More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL) Status RECRUITING Phase NA
NCT07698080 Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation Status NOT_YET_RECRUITING Phase PHASE2
NCT07696169 Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers Status NOT_YET_RECRUITING Phase N/A
NCT07628634 Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors Status RECRUITING Phase EARLY_PHASE1
NCT07621887 Digitalized Exercise Fit Tool Intervention for Adolescents With Blood Cancer Status NOT_YET_RECRUITING Phase NA
NCT07587840 CD19/CD22 CAR-T as First-line Consolidation in Follicular Lymphoma Status RECRUITING Phase PHASE2
NCT07583810 Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07583771 A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma Status NOT_YET_RECRUITING Phase PHASE1
NCT07572175 Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity Status NOT_YET_RECRUITING Phase PHASE2
NCT07566377 Cord Blood Transplantation in Children and Young Adults With Blood Cancer Status RECRUITING Phase PHASE2
NCT07524530 Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers Status NOT_YET_RECRUITING Phase PHASE2
NCT07513129 Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma Status RECRUITING Phase PHASE1
NCT07502872 TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma Status NOT_YET_RECRUITING Phase PHASE2